A number of grant opportunities are available to Baylor College of Medicine researchers. See a funding list from the National Heart, Lung and Blood Institute.
Below, potential grants are offered by the NIH and other institutions related to cardiovascular research.
PAR-14-212: Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UH2/UH3)
Due date: Jan. 16, 2015
Funding: Case-by-case basis for up to three years
The National Center for Advancing Translational Sciences (NCATS) seeks to expand the therapeutics discovery program piloted in 2012 to explore new therapeutic uses for proprietary drug candidates (Agents) across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for Agents from pharmaceutical company partners. A strong application will be supported by scientific evidence that modulation of the Agent’s target will have a positive impact on the disease/condition.
American Heart Association's Winter 2015 Strategically Focused Research Network
Due date: January 30, 2015
Funding: up to $3.7 million, four-year period
This Strategically Focused Research Network (SFRN) funding opportunity issued by the American Heart Association, encourages research grant applications from investigators who propose to study disparities in cardiovascular disease. For the intention of this particular RFA, the AHA’s conceptual framework states that social characteristics of the population such as socioeconomic status, gender, race/ethnicity, language, cultural beliefs, access to care, and residential environment are powerful determinants of health and may impose disparities across the spectrum of cardiovascular disease risk factor prevalence, incidence, diagnosis, treatment, and outcomes. These disparities may be reduced by improved understanding of their biological causes (including heritable and non-heritable causes), improved lifestyle factors, and by tailored treatment modalities and systems change. Elimination of disparities requires input from cross-disciplinary investigation involving diverse approaches. Specifically, this RFA seeks to have basic, clinical and population teams from individual Centers join together and provide proposals which address the topic of cardiovascular disease disparities via their individual areas of expertise.
PAR-12-138: NHLBI Systems Biology Collaborations (R01)
Due date: Jan. 15, 2015
Funding: no limit for five years
This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose collaborative systems biology research projects by multi-disciplinary teams to advance our understanding of normal physiology and perturbations associated with heart, lung, blood, and sleep (HLBS) diseases and disorders. Multi-disciplinary expertise across experimental and computational domains is required, and the multi-PI mechanism is allowed, as integration across these domains is a critical element of the proposed research plan.